| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 205.48 | 84 |
| GSM780708 | Untreated after 4 days (C2_1) | 219.951 | 85 |
| GSM780709 | Untreated after 4 days (C3_1) | 227.675 | 85 |
| GSM780719 | Untreated after 4 days (C1_2) | 207.061 | 84 |
| GSM780720 | Untreated after 4 days (C2_2) | 212.497 | 84 |
| GSM780721 | Untreated after 4 days (C3_2) | 228.564 | 85 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 220.691 | 85 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 219.816 | 85 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 182.701 | 83 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 219.565 | 85 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 176.932 | 82 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 185.116 | 83 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 186.609 | 83 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 202.679 | 84 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 207.413 | 84 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 189.054 | 83 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 195.199 | 83 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 198.739 | 83 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 238.955 | 85 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 241.894 | 85 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 205.78 | 84 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 200.917 | 84 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 215.62 | 84 |